Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/12/2009 | US20090068642 Composition and pharmacology of novel alpha6-containing nicotinic acetylcholine receptors |
03/12/2009 | US20090068641 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
03/12/2009 | US20090068639 System and method of quantitatively determining a biomolecule, system and method of detecting and separating a cell by flow cytometry, and fluorescent silica particles for use in the same, and kit comprising plural kinds of the silica particles in combination |
03/12/2009 | US20090068636 Viral protein |
03/12/2009 | US20090068634 Substrates and internal standards for mass spectrometry detection |
03/12/2009 | US20090068299 ESTROGENIC EXTRACTS OF Pueraria lobata Willd. Ohwi of the Leguminosae Family AND USES THEREOF |
03/12/2009 | US20090068298 ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF |
03/12/2009 | US20090068297 ESTROGENIC EXTRACTS OF Scuttelaria barbata D. Don of the Labiatae Family AND USES THEREOF |
03/12/2009 | US20090068294 ESTROGENIC EXTRACTS OF Rheum palmatum L of the Polygonaceae family AND USES THEREOF |
03/12/2009 | US20090068293 ESTROGENIC EXTRACTS OF Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family AND USES THEREOF |
03/12/2009 | US20090068235 Immunogenic cd19 peptides |
03/12/2009 | US20090068224 Method to identify polypeptide toll-like receptor (tlr) ligands |
03/12/2009 | US20090068221 Virus-like particles as vaccines for paramyxovirus |
03/12/2009 | US20090068210 Immunotherapy for hematological malignancies |
03/12/2009 | US20090068209 Cytotoxic Lymphocyte |
03/12/2009 | US20090068202 Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
03/12/2009 | US20090068201 Methods of treatment using antibodies to neutrokine-alpha |
03/12/2009 | US20090068194 Antibodies and Their Use In The Treatment, Prevention and Diagnosis of a Disease Associated With SOD1 Abnormalities |
03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
03/12/2009 | US20090068191 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of the Pseudomonas Aeruginosa IATS 011 Serotype |
03/12/2009 | US20090068189 Monoclonal Antibody to Human TGF-Beta Induced Gene-H3 and Use Thereof |
03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
03/12/2009 | US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor |
03/12/2009 | US20090068186 MAP3Ks as modifiers of the p53 pathway and methods of use |
03/12/2009 | US20090068182 Cytotoxicity mediation of cells evidencing surface expression of CD9 |
03/12/2009 | US20090068181 Bispecific antibodies |
03/12/2009 | US20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin |
03/12/2009 | US20090068172 Compositions and methods comprising binding proteins for adalimumab |
03/12/2009 | US20090068159 Insecticidal Compositions and Methods for Making Insect-Resistant Transgenic Plants |
03/12/2009 | US20090068158 Thymidylate kinase mutants and uses thereof |
03/12/2009 | US20090068157 Derivation of unlimited quantities of neutrophils on monocyte/dendritic cells |
03/12/2009 | US20090068156 Treatment of muscular dystrophy with cord blood cells |
03/12/2009 | US20090068154 Cell Composition for Transplant |
03/12/2009 | US20090068153 Cell composition for tissue regeneration |
03/12/2009 | US20090068141 Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer |
03/12/2009 | US20090068110 Antibodies to insulin-like growth factor receptor |
03/12/2009 | US20090068109 Anti-mcp-1 antibodies, compositions, methods and uses |
03/12/2009 | US20090068107 Enzyme regulating ether lipid signaling pathways |
03/12/2009 | US20090068104 Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use |
03/12/2009 | US20090068100 Cancerous disease modifying antibodies |
03/12/2009 | US20090068099 Cancerous disease modifying antibodies |
03/12/2009 | US20090068098 Antibodies and related molecules that bind to 58p1d12 proteins |
03/12/2009 | US20090068095 Carbonic anhydrase ix (g250) anitbodies and methods of use thereof |
03/12/2009 | DE102007043131A1 De novo Formierung künstlicher Chromosomen aus prä-fabrizierten Multigenkonstrukten in primären Zellen zur Erzeugung von Organen für die Transplantationsmedizin/Xenotransplantation De novo formation of artificial chromosomes from pre-fabricated Multigenkonstrukten in primary cells for the production of organs for transplantation medicine / xenotransplantation |
03/12/2009 | CA2704730A1 Cell composition for tissue regeneration |
03/12/2009 | CA2699663A1 Non-invasive automated cell proliferation apparatus |
03/12/2009 | CA2698988A1 Composition for separating spermatozoa from a semen sample |
03/12/2009 | CA2698287A1 Antibodies and related molecules that bind to 24p4c12 proteins |
03/12/2009 | CA2698125A1 Alternative methods for the biosynthesis of gaba |
03/12/2009 | CA2698091A1 Wnt pathway stimulation in reprogramming somatic cells |
03/12/2009 | CA2697519A1 Biologically active c-terminal arginine-containing peptides |
03/12/2009 | CA2697518A1 A feeder cell-free culture medium and system |
03/12/2009 | CA2696827A1 Environmentally-friendly multi-layer flexible film having barrier properties |
03/11/2009 | EP2034030A2 Novel compositions and methods for cancer |
03/11/2009 | EP2034023A1 C-C CKR-5 ,CC-Chemikines receptor, derivatives thereof and their uses |
03/11/2009 | EP2034019A1 Composition for nucleic-acid introduction |
03/11/2009 | EP2034018A1 Genetically modified animal and use thereof |
03/11/2009 | EP2034013A1 Process for the production of bromelain by means of substances that induce proteins in pineapple plants |
03/11/2009 | EP2034011A1 Cell cluster comprising plural kinds of cells derived from soma with ability to form primitive organ-like structure |
03/11/2009 | EP2034010A1 Compositions suitable for repair and/or treatment of injured spinal tissue |
03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
03/11/2009 | EP2033972A1 Screening method for candidate drugs |
03/11/2009 | EP2033970A2 WNT-1 inducible genes |
03/11/2009 | EP2033659A2 Inhibitors of complement activation |
03/11/2009 | EP2033514A2 Carbon Monoxide Improves Outcomes in Cell and Organ Transplants and Suppresses Apoptosis |
03/11/2009 | EP2033513A1 Procedure for the preparation of unilamellar vesicles for cryopreservation and the culture of stem cells and embryos |
03/11/2009 | EP2032695A2 Cd127 expression inversely correlates with foxp3 and suppressive function of cd4+ tregs |
03/11/2009 | EP2032694A1 Compositions enriched in neoplastic stem cells and methods comprising same |
03/11/2009 | EP2032693A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais) |
03/11/2009 | EP2032692A2 Method of culturing mesenchymal stem cells |
03/11/2009 | EP2032691A2 Processing procedure for peripheral blood stem cells |
03/11/2009 | EP2032690A2 Method for the in vitro preparation of living cells and/or cell accumulations from tissue |
03/11/2009 | EP2032689A1 Serum-free media and their uses for chondrocyte expansion |
03/11/2009 | EP2032688A1 Cell culture apparatus, method for producing the apparatus and cell culture method |
03/11/2009 | EP2032169A2 Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap |
03/11/2009 | EP1910515A4 Improved methods and compositions for increasing longevity and protein yield from a cell culture |
03/11/2009 | EP1389228B1 Detergent compositions comprising bacillus subtilis pectate lyases |
03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
03/11/2009 | EP1327145B1 Cells having a spectral signature, and methods of preparation and use thereof |
03/11/2009 | EP1325127B1 Method for the production of vitamin k-dependent proteins |
03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
03/11/2009 | CN101384902A Compositions and methods related to controlled gene expression using viral vectors |
03/11/2009 | CN101384710A Nicotiana nucleic acid molecules and uses thereof |
03/11/2009 | CN101384708A Collection and selection methods of an embryonic- like stem cell population from human adult periodontal follicular tissues |
03/11/2009 | CN101384707A A method for osteogenic differentiation of bone marrow stem cells (BMSC) and uses thereof |
03/11/2009 | CN101384706A Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof |
03/11/2009 | CN101384705A Extracellular matrix components for expansion or differentiation of hepatic progenitors |
03/11/2009 | CN101384704A Resorbable cornea button |
03/11/2009 | CN101384703A A method for obtaining a xeno-free hBS cell line |
03/11/2009 | CN101384702A Mesenchymal stem cells and uses therefor |
03/11/2009 | CN101384615A Novel gene products from bacillus licheniformis forming or decomposing polyamino acids and improved biotechnological production methods based thereon |
03/11/2009 | CN101381706A Human liver cancer high-transfer cell strain with stable expression of fluorescent protein and construction method thereof |
03/11/2009 | CN101381705A Method for loading erythrocyte with trehalose |
03/11/2009 | CN101381704A Purification cultivation method of human prolactinomas cell |
03/11/2009 | CN101381703A Method and equipment for improving dissolution of cellular content |
03/11/2009 | CN101381702A Cell culture medium without animal component |
03/11/2009 | CN101381701A Method for amplifying candidate stem cell in vitro |